Condensed Consolidating Statement of Cash Flows (Detail) (USD $) | 6 Months Ended |
In Thousands, unless otherwise specified | 2-May-14 | Apr. 26, 2013 |
Cash Flows Provided (Used) by Operating Activities | ' | ' |
Net earnings (loss) including noncontrolling interests | $67,365 | $61,599 |
Depreciation & amortization | 59,282 | 56,288 |
Deferred income taxes | -8,410 | -5,676 |
Share-based compensation | 6,648 | 5,658 |
Gain on sale of capital assets | 0 | -695 |
Working capital changes, net of effect of acquisitions: | ' | ' |
Accounts receivable | 33,331 | 41,591 |
Inventories | -33,485 | -18,279 |
Prepaid expenses | -8,072 | -1,974 |
Other current assets | -276 | -281 |
Accounts payable | -10,650 | 422 |
Accrued liabilities | -13,224 | -13,587 |
Federal & foreign income taxes | -3,754 | -2,808 |
Other liabilities | -1,587 | -3,212 |
Other, net | -2,716 | 3,638 |
Net Cash Provided (Used) by Operating Activities | 84,452 | 122,684 |
Cash Flows Provided (Used) by Investing Activities | ' | ' |
Purchases of capital assets | -21,297 | -25,085 |
Proceeds from sale of capital assets | 0 | 695 |
Acquisitions of business, net of cash acquired | -44,043 | -40,689 |
Net cash provided by (used in) investing activities | -65,340 | -65,079 |
Cash Flows Provided (Used) by Financing Activities | ' | ' |
Proceeds provided by stock issuance under employee stock plans | 22,957 | 15,201 |
Excess tax benefits from stock options exercises | 5,297 | 1,820 |
Repayment of long-term credit facilities | -25,000 | -40,000 |
Repayment of long-term debt | -19,302 | -197,458 |
Proceeds from issuance of long-term credit facilities | 25,000 | 175,000 |
Dividends paid to noncontrolling interests | -780 | -962 |
Debt and other issuance costs | 0 | -453 |
Net change in intercompany financing | 0 | 0 |
Net Cash Provided (Used) by Financing Activities | 8,172 | -46,852 |
Effect of foreign exchange rates on cash and cash equivalents | 981 | -2,251 |
Net increase (decrease) in cash and cash equivalents | 28,265 | 8,502 |
Cash and Cash Equivalents - Beginning of Period | 179,178 | 160,675 |
Cash and Cash Equivalents - End of Period | 207,443 | 169,177 |
Parent Company | ' | ' |
Cash Flows Provided (Used) by Operating Activities | ' | ' |
Net earnings (loss) including noncontrolling interests | 67,365 | 61,599 |
Depreciation & amortization | 0 | 0 |
Deferred income taxes | -2,708 | 13,077 |
Share-based compensation | 0 | 0 |
Gain on sale of capital assets | 0 | 0 |
Working capital changes, net of effect of acquisitions: | ' | ' |
Accounts receivable | -257 | -682 |
Inventories | 0 | 0 |
Prepaid expenses | 33 | -63 |
Other current assets | 0 | 42 |
Accounts payable | -565 | 122 |
Accrued liabilities | -6,625 | -3,117 |
Federal & foreign income taxes | -6,803 | 2,831 |
Other liabilities | 5,308 | 7,824 |
Other, net | -242 | 1,284 |
Net Cash Provided (Used) by Operating Activities | 55,506 | 82,917 |
Cash Flows Provided (Used) by Investing Activities | ' | ' |
Purchases of capital assets | -149 | -35 |
Proceeds from sale of capital assets | 0 | 0 |
Acquisitions of business, net of cash acquired | 0 | 0 |
Net cash provided by (used in) investing activities | -149 | -35 |
Cash Flows Provided (Used) by Financing Activities | ' | ' |
Proceeds provided by stock issuance under employee stock plans | 22,957 | 15,201 |
Excess tax benefits from stock options exercises | 5,297 | 1,820 |
Repayment of long-term credit facilities | -25,000 | -40,000 |
Repayment of long-term debt | -4,375 | -175,000 |
Proceeds from issuance of long-term credit facilities | 25,000 | 175,000 |
Dividends paid to noncontrolling interests | 0 | 0 |
Debt and other issuance costs | 0 | -453 |
Net change in intercompany financing | -77,490 | -65,217 |
Net Cash Provided (Used) by Financing Activities | -53,611 | -88,649 |
Effect of foreign exchange rates on cash and cash equivalents | 5 | -5 |
Net increase (decrease) in cash and cash equivalents | 1,751 | -5,772 |
Cash and Cash Equivalents - Beginning of Period | 7,826 | 16,770 |
Cash and Cash Equivalents - End of Period | 9,577 | 10,998 |
Guarantor Subsidiaries | ' | ' |
Cash Flows Provided (Used) by Operating Activities | ' | ' |
Net earnings (loss) including noncontrolling interests | 41,335 | 46,563 |
Depreciation & amortization | 22,722 | 20,776 |
Deferred income taxes | 16 | -325 |
Share-based compensation | 2,891 | 2,360 |
Gain on sale of capital assets | 0 | -308 |
Working capital changes, net of effect of acquisitions: | ' | ' |
Accounts receivable | 11,715 | 10,653 |
Inventories | -7,944 | -8,887 |
Prepaid expenses | -3,634 | -1,519 |
Other current assets | 1 | 415 |
Accounts payable | -132 | -506 |
Accrued liabilities | -1,292 | -2,171 |
Federal & foreign income taxes | 22,219 | -2,467 |
Other liabilities | 64 | -7,058 |
Other, net | -3,170 | 5,789 |
Net Cash Provided (Used) by Operating Activities | 84,791 | 63,315 |
Cash Flows Provided (Used) by Investing Activities | ' | ' |
Purchases of capital assets | -7,833 | -8,495 |
Proceeds from sale of capital assets | 0 | 308 |
Acquisitions of business, net of cash acquired | -44,043 | 0 |
Net cash provided by (used in) investing activities | -51,876 | -8,187 |
Cash Flows Provided (Used) by Financing Activities | ' | ' |
Proceeds provided by stock issuance under employee stock plans | 0 | 0 |
Excess tax benefits from stock options exercises | 0 | 0 |
Repayment of long-term credit facilities | 0 | 0 |
Repayment of long-term debt | -205 | -165 |
Proceeds from issuance of long-term credit facilities | 0 | 0 |
Dividends paid to noncontrolling interests | 0 | 0 |
Debt and other issuance costs | 0 | 0 |
Net change in intercompany financing | -32,008 | -54,969 |
Net Cash Provided (Used) by Financing Activities | -32,213 | -55,134 |
Effect of foreign exchange rates on cash and cash equivalents | -43 | -9 |
Net increase (decrease) in cash and cash equivalents | 659 | -15 |
Cash and Cash Equivalents - Beginning of Period | 4,876 | 1,324 |
Cash and Cash Equivalents - End of Period | 5,535 | 1,309 |
Non-Guarantor Subsidiaries | ' | ' |
Cash Flows Provided (Used) by Operating Activities | ' | ' |
Net earnings (loss) including noncontrolling interests | 32,370 | 22,787 |
Depreciation & amortization | 36,560 | 35,512 |
Deferred income taxes | -5,718 | -18,428 |
Share-based compensation | 3,757 | 3,298 |
Gain on sale of capital assets | 0 | -387 |
Working capital changes, net of effect of acquisitions: | ' | ' |
Accounts receivable | 21,873 | 31,620 |
Inventories | -25,541 | -9,392 |
Prepaid expenses | -4,471 | -392 |
Other current assets | -277 | -738 |
Accounts payable | -9,953 | 806 |
Accrued liabilities | -5,307 | -8,299 |
Federal & foreign income taxes | -19,170 | -3,172 |
Other liabilities | -6,959 | -3,978 |
Other, net | 696 | -3,435 |
Net Cash Provided (Used) by Operating Activities | 17,860 | 45,802 |
Cash Flows Provided (Used) by Investing Activities | ' | ' |
Purchases of capital assets | -13,315 | -16,555 |
Proceeds from sale of capital assets | 0 | 387 |
Acquisitions of business, net of cash acquired | 0 | -40,689 |
Net cash provided by (used in) investing activities | -13,315 | -56,857 |
Cash Flows Provided (Used) by Financing Activities | ' | ' |
Proceeds provided by stock issuance under employee stock plans | 0 | 0 |
Excess tax benefits from stock options exercises | 0 | 0 |
Repayment of long-term credit facilities | 0 | 0 |
Repayment of long-term debt | -14,722 | -22,293 |
Proceeds from issuance of long-term credit facilities | 0 | 0 |
Dividends paid to noncontrolling interests | -780 | -962 |
Debt and other issuance costs | 0 | 0 |
Net change in intercompany financing | 35,793 | 50,836 |
Net Cash Provided (Used) by Financing Activities | 20,291 | 27,581 |
Effect of foreign exchange rates on cash and cash equivalents | 1,019 | -2,237 |
Net increase (decrease) in cash and cash equivalents | 25,855 | 14,289 |
Cash and Cash Equivalents - Beginning of Period | 166,476 | 142,581 |
Cash and Cash Equivalents - End of Period | 192,331 | 156,870 |
Eliminations | ' | ' |
Cash Flows Provided (Used) by Operating Activities | ' | ' |
Net earnings (loss) including noncontrolling interests | -73,705 | -69,350 |
Depreciation & amortization | 0 | 0 |
Deferred income taxes | 0 | 0 |
Share-based compensation | 0 | 0 |
Gain on sale of capital assets | 0 | 0 |
Working capital changes, net of effect of acquisitions: | ' | ' |
Accounts receivable | 0 | 0 |
Inventories | 0 | 0 |
Prepaid expenses | 0 | 0 |
Other current assets | 0 | 0 |
Accounts payable | 0 | 0 |
Accrued liabilities | 0 | 0 |
Federal & foreign income taxes | 0 | 0 |
Other liabilities | 0 | 0 |
Other, net | 0 | 0 |
Net Cash Provided (Used) by Operating Activities | -73,705 | -69,350 |
Cash Flows Provided (Used) by Investing Activities | ' | ' |
Purchases of capital assets | 0 | 0 |
Proceeds from sale of capital assets | 0 | 0 |
Acquisitions of business, net of cash acquired | 0 | 0 |
Net cash provided by (used in) investing activities | 0 | 0 |
Cash Flows Provided (Used) by Financing Activities | ' | ' |
Proceeds provided by stock issuance under employee stock plans | 0 | 0 |
Excess tax benefits from stock options exercises | 0 | 0 |
Repayment of long-term credit facilities | 0 | 0 |
Repayment of long-term debt | 0 | 0 |
Proceeds from issuance of long-term credit facilities | 0 | 0 |
Dividends paid to noncontrolling interests | 0 | 0 |
Debt and other issuance costs | 0 | 0 |
Net change in intercompany financing | 73,705 | 69,350 |
Net Cash Provided (Used) by Financing Activities | 73,705 | 69,350 |
Effect of foreign exchange rates on cash and cash equivalents | 0 | 0 |
Net increase (decrease) in cash and cash equivalents | 0 | 0 |
Cash and Cash Equivalents - Beginning of Period | 0 | 0 |
Cash and Cash Equivalents - End of Period | $0 | $0 |